Victory Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.5M | Buy |
|
|||||
|
2025
Q2 | $11.7M | Buy |
|
|||||
|
2025
Q1 | $10.2M | Sell |
|
|||||
|
2024
Q4 | $25.9M | Sell |
|
|||||
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $18.9M | Buy |
|
|||||
|
2024
Q1 | $18.7M | Buy |
|
|||||
|
2023
Q4 | $15.4M | Buy |
|
|||||
|
2023
Q3 | $7.86M | Buy |
|
|||||
|
2023
Q2 | $6.54M | Sell |
|
|||||
|
2023
Q1 | $8.14M | Sell |
|
|||||
|
2022
Q4 | $13.5M | Buy |
|
|||||
|
2022
Q3 | $10.4M | Buy |
|
|||||
|
2022
Q2 | $8.32M | Sell |
|
|||||
|
2022
Q1 | $7.74M | Buy |
|
|||||
|
2021
Q4 | $1.42M | Sell |
|
|||||
|
2021
Q3 | $2M | Sell |
|
|||||
|
2021
Q2 | $3.81M | Sell |
|
|||||
|
2021
Q1 | $4M | Sell |
|
|||||
|
2020
Q4 | $36.7M | Sell |
|
|||||
|
2020
Q3 | $67.5M | Buy |
|
|||||
|
2020
Q2 | $78.4M | Sell |
|
|||||
|
2020
Q1 | $99.2M | Buy |
|
|||||
|
2019
Q4 | $68.8M | Buy |
|
|||||
|
2019
Q3 | $39.6M | Buy |
|
|||||
|
2019
Q2 | $22.6M | Sell |
|
|||||
|
2019
Q1 | $47.2M | Sell |
|
|||||
|
2018
Q4 | $39.5M | Sell |
|
|||||
|
2018
Q3 | $74.4M | Buy |
|
|||||
|
2018
Q2 | $37M | Sell |
|
|||||
|
2018
Q1 | $47.2M | Buy |
|
|||||
|
2017
Q4 | $51K | Hold |
|
|||||
|
2017
Q3 | $40K | Hold |
|
|||||
|
2017
Q2 | $30K | Buy |
|
|||||
|
2017
Q1 | $28K | Sell |
|
|||||
|
2016
Q4 | $660K | Buy |
|
|||||
|
2016
Q3 | $861K | Buy |
|
|||||
|
2016
Q2 | $26K | Buy |
|
|||||
|
2016
Q1 | $20K | Buy |
|
|||||
|
2015
Q4 | $26K | Buy |
|
|||||
|
2015
Q3 | $17K | Buy |
|
|||||
|
2015
Q2 | $19K | Buy |
|